Johnson & Johnson vs Virgin Galactic Holdings, Inc. — how do they compare? Johnson & Johnson trades at $250.8 (market cap $598.96B), while Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M). The key difference: Johnson & Johnson is far larger — about 1820.2× Virgin Galactic Holdings, Inc.'s market cap, and Johnson & Johnson pays a 2.15% dividend while Virgin Galactic Holdings, Inc. pays none. Which is the better fit depends on your goals.
| JNJ | SPCE | |
|---|---|---|
Market Cap | $598.96B | $329.06M |
Volume | 6,156,228 | — |
Sector | Health | Industrials |
52-Week High | $267.24 | $7.52 |
52-Week Low | $164.36 | $2.17 |
Enterprise Value | $631.90B | $428.90M |
Dividend Yield | 2.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →